Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

47 results about "Ophthalmic Product" patented technology

Primary packaging line for ophthalmic articles

A Primary Packaging Line using a single carrier tray concept allows to have a lean setup of the lens transfer / ripping process from the upstream Inspection Module, blister strip formation after the inspection and a shell reusage system in case of detected missing or multiple lenses by the inspection. The primary packaging line for packaging ophthalmic articles comprises: shell supply and placement station; saline pre-dosing station; lens transfer station; saline main dosing station; lens presence check station; lens and shell reject station; lot sorter station; foil supply and sealing station and blister labeling station.
Owner:ALCON INC

Bifidobacterium bifidum and application thereof in ophthalmic products or products for regulating intestinal flora

ActiveCN120944788BSenses disorderBacteriaDiseaseTear secretion
This invention belongs to the field of biomedicine, specifically relating to a strain of Bifidobacterium bifidum and its application in eye health products. The Bifidobacterium bifidum (… Bifidobacterium bifidum Bifidobacterium bifidum BB00, with accession number CGMCC No. 34389, is a product of this invention. It can improve the clinical symptoms of dry eye syndrome, increase tear secretion, prolong tear film breakup time, reduce ocular surface disease index, alleviate corneal epithelial damage, and regulate palpebral fissure opening. It can also regulate the composition of the intestinal flora, increase flora diversity, and inhibit the growth of pathogenic intestinal bacteria. Bifidobacterium bifidum BB00 not only provides an innovative solution to the clinical pain point of dry eye syndrome, achieving synergistic intervention between intestinal regulation and eye health, but also possesses scientific innovation, clinical effectiveness, and industrialization potential. It has significant value for the application of bacteria and bacterial agents in the biomedical field and for the treatment of ocular surface-intestinal related diseases.
Owner:ZHONGKE WISBIOM(BEIJING)BIOTECHNOLOGY CO LTD